Search research articles
Contact Us
Filters
Showing results (701-710 of 716) with videos related to
Page
of 72
Sort By:
Environmental Science & Technology
|
August 25, 2021
Critical Role of Simultaneous Reduction of Atmospheric Odd Oxygen for Winter Haze Mitigation
Xiao-Feng Huang, Li-Ming Cao, Xu-Dong Tian, et al.
Bioorganic & Medicinal Chemistry
|
March 24, 2015
Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents
Marvin J Meyers, Elizabeth J Anderson, Sarah A McNitt, et al.
Frontiers in Immunology
|
December 15, 2025
Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis
Jun-Zhe Yi, Jie Xu, Jiang-Zheng Zeng, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Evaluation of aminohydantoins as a novel class of antimalarial agents
Marvin J Meyers, Micky D Tortorella, Jing Xu, et al.
Cell Reports. Medicine
|
October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition
Yu Chang, Xiaoju Wang, Jianzhang Yang, et al.
The Journal of Clinical Investigation
|
September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models
Yi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 7, 2026
A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer
Xiaoju Wang, Wenyan Liu, Jiehao Yang, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
Abhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma
Jean Ching-Yi Tien, Yali Zhai, Rong Wu, et al.
Cell Chemical Biology
|
November 28, 2017
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement
James D Vasta, Cesear R Corona, Jennifer Wilkinson, et al.
Page
of 72
Search research articles
Search
Showing results (701-710 of 716) with videos related to
Sort By:
Page
of 72
Environmental Science & Technology
|
August 25, 2021
Critical Role of Simultaneous Reduction of Atmospheric Odd Oxygen for Winter Haze Mitigation
Xiao-Feng Huang, Li-Ming Cao, Xu-Dong Tian, et al.
Bioorganic & Medicinal Chemistry
|
March 24, 2015
Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents
Marvin J Meyers, Elizabeth J Anderson, Sarah A McNitt, et al.
Frontiers in Immunology
|
December 15, 2025
Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis
Jun-Zhe Yi, Jie Xu, Jiang-Zheng Zeng, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Evaluation of aminohydantoins as a novel class of antimalarial agents
Marvin J Meyers, Micky D Tortorella, Jing Xu, et al.
Cell Reports. Medicine
|
October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition
Yu Chang, Xiaoju Wang, Jianzhang Yang, et al.
The Journal of Clinical Investigation
|
September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models
Yi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 7, 2026
A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer
Xiaoju Wang, Wenyan Liu, Jiehao Yang, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
Abhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma
Jean Ching-Yi Tien, Yali Zhai, Rong Wu, et al.
Cell Chemical Biology
|
November 28, 2017
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement
James D Vasta, Cesear R Corona, Jennifer Wilkinson, et al.
Page
of 72